Geode Capital Management LLC Purchases 28,323 Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD)

Geode Capital Management LLC lifted its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 6.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 462,128 shares of the company’s stock after purchasing an additional 28,323 shares during the quarter. Geode Capital Management LLC owned approximately 1.01% of KORU Medical Systems worth $1,262,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of KRMD. XTX Topco Ltd bought a new position in KORU Medical Systems in the third quarter worth $34,000. Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock valued at $168,000 after buying an additional 26,860 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of KORU Medical Systems during the 2nd quarter worth about $107,000. Finally, Meros Investment Management LP boosted its position in shares of KORU Medical Systems by 20.7% during the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after acquiring an additional 137,918 shares in the last quarter. 58.60% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Piper Sandler increased their price target on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday, November 14th. Craig Hallum increased their target price on KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, Canaccord Genuity Group raised their target price on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th.

KORU Medical Systems Price Performance

Shares of KORU Medical Systems stock opened at $4.00 on Friday. The stock has a market capitalization of $183.35 million, a price-to-earnings ratio of -16.00 and a beta of 0.45. The firm’s 50-day moving average price is $3.67 and its two-hundred day moving average price is $2.92. The company has a current ratio of 2.99, a quick ratio of 2.37 and a debt-to-equity ratio of 0.01. KORU Medical Systems, Inc. has a 1-year low of $1.98 and a 1-year high of $4.60.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.